guanabenz has been researched along with adenosine diphosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayashi, J; Ishida, N; Kitamoto, K; Sato, H; Tanaka, Y; Tokuue, J; Watanabe, K | 1 |
1 trial(s) available for guanabenz and adenosine diphosphate
Article | Year |
---|---|
Guanabenz, an antihypertensive centrally acting alpha2-agonist, suppresses morning elevations in aggregation of human platelets.
Topics: Adenosine Diphosphate; Adrenergic alpha-Agonists; Adult; Analysis of Variance; Circadian Rhythm; Epinephrine; Guanabenz; Humans; Male; Platelet Aggregation; Receptors, Adrenergic, alpha-2 | 2001 |